The literature suggests that the 28 exon ABCB1 is most commonly produced by normally functioning cells, whereas drug-resistant cancer cells might more frequently produce the slightly longer 29 exon form [19,20,21,22]. This evidence concerns the gene ABCB1 and cancer.